|
|
Volumn 28, Issue 4, 2014, Pages 361-377
|
|
Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications
a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
AZETIDINE DERIVATIVE;
BILE ACID;
CETP PROTEIN, HUMAN;
CHOLESTEROL ESTER TRANSFER PROTEIN;
EZETIMIBE;
FIBRIC ACID DERIVATIVE;
FISH OIL;
GLUCOSE BLOOD LEVEL;
NICOTINIC ACID;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
BLOOD;
DIABETES MELLITUS;
DRUG EFFECTS;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPERLIPIDEMIAS;
LIPID METABOLISM;
METABOLISM;
ANIMALS;
AZETIDINES;
BILE ACIDS AND SALTS;
BLOOD GLUCOSE;
CHOLESTEROL ESTER TRANSFER PROTEINS;
DIABETES MELLITUS;
FIBRIC ACIDS;
FISH OILS;
HUMANS;
HYPERLIPIDEMIAS;
HYPOLIPIDEMIC AGENTS;
LIPID METABOLISM;
NIACIN;
|
|
EID: 85027957106
PISSN: None
EISSN: 15737241
Source Type: Journal
DOI: 10.1007/s10557-014-6534-9 Document Type: Review |
|
Times cited : (44)
|
|
References (0)
|